Abstract
The oral squamous cell carcinoma (OSCC) is a highly aggressive and lethal neoplasm that typically affects the tongue and the floor of mouth in males, smokers and over 50-year-old individuals. The recent rising incidence of OSCC in younger patients (< 40 years old) is altering the lesion epidemiological profile and challenging its treatment. Immunotherapy is the standard or second-line tre…